Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gastrointestinal 1

Conditions

Precancerous Conditions 1Esophageal Neoplasms 1Barrett Esophagus 1Adenocarcinoma Of Esophagus 1

Interventions

Cyclophosphamide 5Decitabine 3Carboplatin 3Busulfan 3Radiotherapy 2Endoscopy 2Chemoradiotherapy 2Capecitabine 2sintilimab 1sargramostim 1liposomal doxorubicin 1fludarabine phosphate 1exemestane 1camrelizumab 1alethine 1Watchful Waiting 1Vincristine 1Ultrasonography, Doppler 1Rifampin 1Proton Therapy 1Polymerase Chain Reaction 1Patient Reported Outcome Measures 1Papanicolaou Test 1Paclitaxel 1Observation 1Mycophenolic Acid 1Methylation 1Mass Spectrometry 1Liver Transplantation 1Laparoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × High-Throughput Screening Assays × Other neoplasm × Clear all
NCT00987857 2017-08-22

Endoscopy Every 2 Years or Only as Needed in Monitoring Patients With Barrett Esophagus

Gloucestershire Hospitals NHS Foundation Trust

Phase NA Unknown
3,400 enrolled
GastrointestinalOther neoplasm

Adenocarcinoma Of Esophagus, Barrett Esophagus, Esophageal Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡